191 related articles for article (PubMed ID: 35280981)
1. Radiation Recall Pneumonitis Induced by Sintilimab: A Case Report and Literature Review.
Wang M; Xu S; Zhu H
Front Immunol; 2022; 13():823767. PubMed ID: 35280981
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer.
Lu X; Wang J; Zhang T; Zhou Z; Deng L; Wang X; Wang W; Liu W; Tang W; Wang Z; Wang J; Jiang W; Bi N; Wang L
Front Immunol; 2022; 13():918787. PubMed ID: 35795657
[TBL] [Abstract][Full Text] [Related]
3. Incidence, risk factors, and CT characteristics of radiation recall pneumonitis induced by immune checkpoint inhibitor in lung cancer.
Cousin F; Desir C; Ben Mustapha S; Mievis C; Coucke P; Hustinx R
Radiother Oncol; 2021 Apr; 157():47-55. PubMed ID: 33453313
[TBL] [Abstract][Full Text] [Related]
4. Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer.
Ding X; Ji W; Li J; Zhang X; Wang L
Radiat Oncol; 2011 Mar; 6():24. PubMed ID: 21375774
[TBL] [Abstract][Full Text] [Related]
5. Radiation recall pneumonitis triggered by an immune checkpoint inhibitor following re-irradiation in a lung cancer patient: a case report.
Ye X; Yang J; Stebbing J; Peng L
BMC Pulm Med; 2022 Feb; 22(1):54. PubMed ID: 35123465
[TBL] [Abstract][Full Text] [Related]
6. Pembrolizumab-induced Radiation Recall Pneumonitis After the Resolution of Typical Asymptomatic Radiation Pneumonitis.
Itamura H; Ohguri T; Yahara K; Nakahara S; Kakinouchi S; Morisaki T; Yatera K; Tanaka F; Korogi Y
J UOEH; 2020; 42(3):261-266. PubMed ID: 32879190
[TBL] [Abstract][Full Text] [Related]
7. Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade II after radiotherapy - a single-centre experience.
Henkenberens C; Janssen S; Lavae-Mokhtari M; Leni K; Meyer A; Christiansen H; Bremer M; Dickgreber N
Radiat Oncol; 2016 Feb; 11():12. PubMed ID: 26830686
[TBL] [Abstract][Full Text] [Related]
8. Radiation recall pneumonitis after COVID-19 vaccination.
Shinada K; Murakami S; Yoshida D; Saito H
Thorac Cancer; 2022 Jan; 13(1):144-145. PubMed ID: 34791816
[No Abstract] [Full Text] [Related]
9. Relationship Between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients With Advanced Non-Small-Cell Lung Cancer.
Voong KR; Hazell SZ; Fu W; Hu C; Lin CT; Ding K; Suresh K; Hayman J; Hales RK; Alfaifi S; Marrone KA; Levy B; Hann CL; Ettinger DS; Feliciano JL; Peterson V; Kelly RJ; Brahmer JR; Forde PM; Naidoo J
Clin Lung Cancer; 2019 Jul; 20(4):e470-e479. PubMed ID: 31031204
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes and radiation pneumonitis after concurrent EGFR-tyrosine kinase inhibitors and radiotherapy for unresectable stage III non-small cell lung cancer.
Xu K; Liang J; Zhang T; Zhou Z; Chen D; Feng Q; Xiao Z; Hui Z; Lu J; Wang X; Deng L; Liu W; Wang J; Zhai Y; Wang J; Bi N; Wang L
Thorac Cancer; 2021 Mar; 12(6):814-823. PubMed ID: 33501781
[TBL] [Abstract][Full Text] [Related]
11. Salivary metabolites as novel independent predictors of radiation pneumonitis.
Shiraishi S; Sugimoto M; Tokuuye K
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17559-17566. PubMed ID: 37906353
[TBL] [Abstract][Full Text] [Related]
12. Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study.
Yue J; Shi Q; Xu T; Jeter M; Chen TY; Komaki R; Gomez DR; Pan T; Cleeland CS; Liao Z; Wang XS
Qual Life Res; 2018 Jun; 27(6):1563-1570. PubMed ID: 29549533
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for radiation-induced pulmonary toxicity after three-dimensional conformal chemoradiation in locally advanced non-small-cell lung cancer.
Moreno M; Aristu J; Ramos LI; Arbea L; López-Picazo JM; Cambeiro M; Martínez-Monge R
Clin Transl Oncol; 2007 Sep; 9(9):596-602. PubMed ID: 17921108
[TBL] [Abstract][Full Text] [Related]
14. Risk factor analysis of the development of severe radiation pneumonitis in patients with non-small cell lung cancer treated with curative radiotherapy, with focus on underlying pulmonary disease.
Kim H; Hwang J; Kim SM; Choi J; Yang DS
BMC Cancer; 2023 Oct; 23(1):992. PubMed ID: 37848850
[TBL] [Abstract][Full Text] [Related]
15. Radiation Recall Pneumonitis Anticipates Bilateral Immune-Induced Pneumonitis in Non-Small Cell Lung Cancer.
Torresan S; Zussino G; Cortiula F; Follador A; Fasola G; Girometti R; Cereser L
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835802
[TBL] [Abstract][Full Text] [Related]
16. Radiation recall pneumonitis induced by epidermal growth factor receptor-tyrosine kinase inhibitor in patients with advanced nonsmall-cell lung cancer.
Chiang CL; Chen YW; Wu MH; Huang HC; Tsai CM; Chiu CH
J Chin Med Assoc; 2016 May; 79(5):248-55. PubMed ID: 27036494
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the risk factors of radiation pneumonitis and the predictive ability of dosiomics in non-small-cell lung cancer.
Zhuang L; Bai X; Chen Y; Zhang D; Sheng L; Du X
Future Oncol; 2023 Oct; 19(32):2157-2169. PubMed ID: 37887073
[No Abstract] [Full Text] [Related]
18. Radiation recall pneumonitis induced by PD-1/PD-L1 blockades: mechanisms and therapeutic implications.
Teng F; Li M; Yu J
BMC Med; 2020 Sep; 18(1):275. PubMed ID: 32943072
[TBL] [Abstract][Full Text] [Related]
19. Nivolumab-induced radiation recall pneumonitis in non-small-cell lung cancer patients with thoracic radiation therapy.
Noda-Narita S; Naito T; Udagawa H; Goto K; Miyawaki T; Mamesaya N; Nakashima K; Kenmotsu H; Shimokawaji T; Kato T; Hakozaki T; Okuma Y; Nakamura M; Nakayama Y; Watanabe H; Kusumoto M; Ohe Y; Horinouchi H
Cancer Sci; 2023 Feb; 114(2):630-639. PubMed ID: 36285515
[TBL] [Abstract][Full Text] [Related]
20. Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis.
Onishi H; Kuriyama K; Yamaguchi M; Komiyama T; Tanaka S; Araki T; Nishikawa K; Ishihara H
Lung Cancer; 2003 Apr; 40(1):79-84. PubMed ID: 12660011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
